Iovance Biotherapeutics, Inc.
$3.69B- Market cap
- $3.98B
- Debt
- +$1.00M
- Cash
- −$296.98M
Capital structure 100% equity / 0% debt · EV / Revenue 13.99x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
IOVA · current priceP/S 15.11x
$8.79Latest market snapshot
Implied fair value · at ALK's multiple
$0.1997.8% below market
0.58 IOVA revenue / share×0.33x ALK P/S=$0.19
Market $8.79Implied $0.19
ALK · current priceP/S 0.33x
$42.04Latest market snapshot
Implied fair value · at IOVA's multiple
$1,927.884,485.8% above market
127.59 ALK revenue / share×15.11x IOVA P/S=$1,927.88
Market $42.04Implied $1,927.88